Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_assertion type Assertion NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_head.
- NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_assertion description "[Treatment of ovarian cancer HEY cells with 500 nM 5alpha-dihydrotestosterone (DHT), but not estradiol-17beta or progesterone, for 60 h down-regulated the expression of mRNA for TGF-beta receptors I and II (TbetaR-I and TbetaR-II), betaglycan, and endoglin but had no effect on TGF-beta1 mRNA levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.
- NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_assertion evidence source_evidence_literature NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.
- NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_assertion SIO_000772 10706107 NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.
- NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_assertion wasDerivedFrom befree-20140225 NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.
- NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_assertion wasGeneratedBy ECO_0000203 NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.